ClinVar Miner

Submissions for variant NM_032444.4(SLX4):c.1929G>C (p.Leu643Phe)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV003151656 SCV003840063 uncertain significance not specified 2022-05-09 no assertion criteria provided clinical testing DNA sequence analysis of the SLX4 gene demonstrated a sequence change, c.1929G>C, in exon 9 that results in an amino acid change, p.Leu643Phe. This sequence change does not appear to have been previously described in individuals with SLX4-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.00080% (dbSNP rs778062467). The p.Leu643Phe change affects a poorly conserved amino acid residue located in a domain of the SLX4 protein that is not known to be functional. The p.Leu643Phe substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Leu643Phe change remains unknown at this time.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.